Clinical Trial Update: Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation. [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing flecainide CR to placebo in early treatment of atrial fibrillation; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Flecainide CR (flecainide)

Snippet

Sponsor: MEDA Pharma GmbH & Co. KG | Conditions: Atrial Fibrillation | Phase 4 | Status: TERMINATED